Provided by Tiger Trade Technology Pte. Ltd.

GoodRx Holdings, Inc.

3.45
-0.1100-3.09%
Post-market: 3.480.0277+0.80%19:54 EDT
Volume:1.75M
Turnover:6.11M
Market Cap:1.18B
PE:72.68
High:3.60
Open:3.60
Low:3.44
Close:3.56
52wk High:5.81
52wk Low:1.77
Shares:341.15M
Float Shares:93.82M
Volume Ratio:0.81
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0475
EPS(LYR):0.0854
ROE:2.52%
ROA:3.05%
PB:1.82
PE(LYR):40.39

Loading ...

BRIEF-Goodrx To Expand Employer-Sponsored Access To Zepbound® Kwikpen®

Reuters
·
Mar 06

GoodRx Partners With Eli Lilly to Expand Employer Access to Zepbound KwikPen

Reuters
·
Mar 06

GoodRx Holdings Inc - Collaborates With Eli Lilly to Expand Employer Access to Zepbound Kwikpen

THOMSON REUTERS
·
Mar 06

GoodRx Holdings Inc - Self-Insured Employers Can Subsidize $449 Lilly Price for Zepbound Kwikpen via GoodRx

THOMSON REUTERS
·
Mar 06

U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan Materials

Reuters
·
Mar 04

GoodRx price target lowered to $3.50 from $7 at Wells Fargo

TIPRANKS
·
Mar 04

GoodRx Holdings Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 04

GoodRx Holdings Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Mar 03

GoodRx price target lowered to $2.50 from $4 at Goldman Sachs

TIPRANKS
·
Mar 02

GoodRx Earnings Call Marks Transitional Reset Year

TIPRANKS
·
Mar 02

Assessing GoodRx Holdings (GDRX) Valuation After Employer Direct Launch And Post Earnings Analyst Shifts

Simply Wall St.
·
Feb 28

GoodRx Announces Resignation of Board Member Dipanjan Deb

TIPRANKS
·
Feb 28

GoodRx Director Dipanjan Deb Resigns

Reuters
·
Feb 28

GoodRx 2026 Guidance Signals Material Reset, Morgan Stanley Says

MT Newswires Live
·
Feb 28

GoodRx price target lowered to $2 from $4 at UBS

TIPRANKS
·
Feb 27

GoodRx Holdings Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
Feb 27

Morgan Stanley Cuts Price Target on GoodRx Holdings to $3 From $4, Keeps Equalweight Rating

MT Newswires Live
·
Feb 27

U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler

Reuters
·
Feb 27

GoodRx Holdings Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS
·
Feb 27

GoodRx downgraded to Neutral at JPMorgan on ‘murky’ outlook

TIPRANKS
·
Feb 27